Randomised study to compare the efficacy and safety of isapgol plus atorvastatin versus atorvastatin alone in subjects with hypercholesterolemia

Journal of the Indian Medical Association

Volumn 105, Issue 3, 2007, Pages

  Jayaram, S ^a   Prasad, H B ^b   Sovani, V B ^c   Langade, D G ^a   Mane, P R ^c  

^a GRANT MEDICAL COLLEGE   (India)

^b B J MEDICAL COLLEGE   (India)

^c Organon (India) Limited   (India)

Author keywords

Atorvastatin; Isapgol; Low density lipoprotein cholesterol; Psyllium; Statin

Indexed keywords

ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISPAGULA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NATUROLAX; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOATING; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; FLATULENCE; HEADACHE; HEART HEMODYNAMICS; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; MUSCLE WEAKNESS; MYALGIA; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT;

EID: 34948903350     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Stein E, Stender S, Mata P, et al - Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Am Heart J 2004; 148: 447-55.
2. Jones PH - Statins as the cornerstone of drug therapy for dysiipidemia: monotherapy and combination therapy options. Am Heart J 2004; 148: S9-13.
3. Streja D - Combination therapy for the treatment of dyslipidemia. Curr Opin Invest Drugs 2004; 5: 306-12.
4. Manhas A, Farmer JA - Hypolipidemic therapy and cholesterol absorption. Curr Atheroscler Rep 2004; 6: 89-93.
5. Anderson JW, Allgood LD, Lawrence A, et al - Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr 2000; 71: 472-9.
6. Moreyra AE, Wilson AC, Koraym A - Effect of combining psyllium fiber with simvastatin in lowering cholesterol. Arch Intern Med 2005; 165: 1161-6.
7. Anderson JW, Zettwoch N, Feldman T, Tietyen-Clark J, Oeltgen P, Bishop CW - Cholesterol-lowering effects of psyllium hydrophijic mucilloid for hypercholesterolemic men. Arch Intern Med 1988; 148: 292-6.
8. Levin EG, Miller VT, Muesing RA, Stoy DB, Balm TK, LaRosa JC - Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Arch Intern Med 1990; 150: 1822-7.
9. Anderson JW, Allgood LU, Lawrence A, et al - Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr 2000; 71: 472-9.
10. Anderson JW, Davidson JH Blonde L, et al - Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia. Am J Clin Nutr 2000; 71: 1433-8.
11. Matheson HB, Colon IS, Story JA - Cholesterol 7 alpha-hydroxylase activity is increased by dietary modification with psyllium hydrocolloid, pectin, cholesterol and cholestyramine in rats. J Nutr 1995; 125: 454-8.
12. Vergara-Jimenez M, Conde K, Erickson SK. Fernandez ML - Hypolipidemic mechanisms of pectin and psyllium in guinea pigs fed high fat-sucrose diets: alterations on hepatic cholesterol metabolism. J Lipid Res 1998; 39: 1455-65.
13. Everson GT, Daggy BP, McKinley C, Story JA - Effects of psyllium hydrophilic mucilloid on LDL-cholesterol and bile acid synthesis in hypercholesterolemic men. J Lipid Res 1992; 33: 1183-92.
14. Spence JD, Huff MW, Heidenheim P, Viswanatha A, Munoz C. Lindsay R, et al - Combination therapy with colestipol and psyllium mucilloid in patients with hyperlipidemia. Ann Intern Med 1995; 123: 493-9.
15. Grundy SM, Cleeman JL, Merz CN, et al - Implications of recent clinical trials for the National Cholesterol Education Program, Adult Treatment Panel III Guidelines (published correction appears in Circulation 2004; 110:763): National Heart, Lung and Blood Institute; American College of Cardiology Foundation; American heart Association. Circulation 2004; 110: 227-39.
16. Expert Panel on Detection, Evaluation and Treatment of high blood cholesterol in adults - Executive summary of the Third Report of National Cholesterol Education Program (NECP): Expert Panel on Detection, Evaluation and Treatment of high blood cholesterol in adults, (Adult Treatment Panel III)[Abstract]. JAMA 2001; 285: 2486-97.